It’s one thing if your cup runneth over. It’s another if it obstructeth your organs. Last year, doctors treated a woman in ...

In participants with highly active disease, the unadjusted annualized relapse rate (ARR) at Week 96 was 0.145 for BRIUMVI versus 0.496 for teriflunomide, representing a 70.8% relative reduction ...

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI® (ublituximab-xiiy) data in patients with relapsing forms of multiple sclerosis (RMS), ...

Johnson & Johnson , a worldwide leader in multiple myeloma therapies, today announced that the U.S. Food and Drug ...

This report describes a female patient in her 60s with an immune-mediated necrotising myopathy (IMNM) occurring after semaglutide use. She was found to have progressive dysphagia, dysphonia, proximal ...

After weeks of doctor visits and her condition worsening, Emma Operacz was given an unexpected diagnosis ...

AstraZeneca and Daiichi Sankyo’s supplemental Biologics License Application (sBLA) for ENHERTU® (fam-trastuzumab deruxtecan-nxki) has been accepted and granted Priority Review in the US for the ...

Updated consensus recommendations provide strategies for preventing both catheter-associated and noncatheter-associated UTIs.

Most people experience a hernia as a bump under the skin. They occur when an internal organ, most often the small intestine, ...

Learn the key warning signs of prostate cancer that men often overlook. Early awareness can make all the difference.

Over three quarters of people on Gazyva plus standard therapy achieved at least a four-point improvement in SRI-4, a measure that assesses disease severity and symptomsGazyva has the potential to ...

Human metapneumovirus could progress to bronchitis or pneumonia. Studies also show dual diagnoses of HMPV, influenza and RSV, resulting in serious and sometimes fatal complications. Studies show ...